SUDOSCAN
THERAPEUTIC AREAS
Diabetes
SUDOSCAN efficacy in early detection of diabetic neuropathy has been demonstrated in several studies.

Neurology
Small fiber neuropathies have been assessed using SUDOSCAN in different diseases and therapeutic areas.

Oncology
SUDOSCAN has demonstrated its clinical utility to detect chemotherapy induced polyneuropathy (CIPN).

Nephrology
SUDOSCAN has demonstrated its clinical utility in Nephrology.

Follow-up
A key clinical application of SUDOSCAN is longitudinal follow-up and patient management.

Diabetes Risk
Objective screening of diabetes risk through non invasive assessment of Sudomotor function using Ezscan score
SCIENCE & RESEARCH
WHO WE ARE
- About Impeto Medical
- Impeto Medical in the World

Scientific news

Scientific news

Scientific newsSebastien2026-05-28T14:23:22+00:00

NephrologyScientific publications
SUDOSCAN in Intradialytic hypotension
SUDOSCAN in Intradialytic hypotension
June 18, 2021

Infectious disease / News / Scientific publications

SUDOSCAN and COVID-19
Sudomotor dysfunction in patients recovered from COVID-19 Anand Hinduja, Abdul [...]

Read Article
Infectious disease / Scientific publications

SUDOSCAN in asymptomatic Hepatitis C
SUDOSCAN detects small fiber neuropathy in asymptomatic hepatitis C virus-related [...]

Read Article
Diabetes / Scientific publications

SUDOSCAN utility to detect foot sudomotor dysfunction in type 1 diabetes without clinical evidence of peripheral neuropathy
SUDOSCAN UTILITY TO DETECT FOOT SUDOMOTOR DYSFUNCTION IN TYPE 1 [...]

Read Article
Diabetes / Scientific publications

Clinical impact of dpp-4 inhibitor on autonomic neuropathy followed up by SUDOSCAN
CLINICAL IMPACT OF DPP-4 INHIBITOR ON AUTONOMIC NEUROPATHY FOLLOWED UP [...]

Read Article

Subscribe to receive our scientific news

Email(Required)

Name(Required)

Events
Sudoscan to Participate in the 4th Multidisciplinary French-Speaking Conference on Amyloidosis
October 31, 2026
Webinar
Webinar : Clinical Impact of Sudoscan use in daily practice: worldwide experience – November the 14th 2025
October 31, 2026
Events
Sudoscan at the 26th EFAS Congress 2025
October 31, 2026

About Sudoscan

Sudoscan is a class IIa Medical device, Manufactured by Impeto Medical, indicated for early identification and follow-up of peripheral autonomic neuropathies.

For professional use only, read instructions before use. This medical device is a regulated health product which bears, under this regulation, the CE mark

Sudoscan in the world

More information

Sudoscan Technology

Contact info

France HEADQUARTERS: 2 rue Maurice Hartmann, 92130 Issy Les Moulineaux
Phone: +33 (0)7 87 20 32 03

Sudoscan USA: 8525 Gibbs Dr Suite 304, San Diego, CA 92123, États-Unis
Phone: 858-450-2800

Promotional Communication. The medical devices SUDOSCAN & EZSCAN are regulated health products under the CE certification, Class IIa, according to the European Medical Device directive – SGS Belgium, notified body 1639. The test allows screening and monitoring of peripheral autonomic neuropathies. It can be performed in diabetic patients or in patients suffering from neurological diseases involving small fibers damage. As with any diagnostic test, its results must be interpreted in a global context including the clinic and other examinations performed. Please read the user manual instructions carefully. Contact our office for more information. Last update: 2021/01/12

Innovations in Autonomic Function Testing

Contact Info

France HEADQUATERS: 2 rue Maurice Hartmann, 92130 Issy Les Moulineaux

Phone: +33 (0)7 87 20 32 03

sudoscan-homepage-photo-2023-6

Discover SudoscanDiscover Sudoscan